A.C. Spyropoulos
W. Ageno
G.W. Albers
C.G. Elliot
J.L. Halperin
W.R. Hiatt
G.A. Maynard
G. Steg
J.I. Weitz
E. Suh
T.E. Spiro
E.S. Barnathan
G.E. Raskob
The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, The Feinstein Institute for Medical Research, and Department of Medicine, Anticoagulation and Clinical Thrombosis Services Northwell Health at Lenox Hill Hospital, New York, United States
University of Insubria, Department of Medicine and Surgery, Varese, Italy
Stanford Stroke Center, Stanford University Medical Center, Stanford, United States
Intermountain Medical Center and the University of Utah, Department of Medicine, Salt Lake City, United States
The Cardiovascular Institute, Mount Sinai Medical Center, New York, United States
University of Colorado School of Medicine, Division of Cardiology, Aurora, United States
CPC Clinical Research, Aurora, United States
University of California, Davis, Davis, California, United States
DHU FIRE, University Paris‐Diderot, Assistance Publique‐Hôpitaux de Paris, and INSERM U‐1148, Paris, France
Imperial College, Royal Brompton Hospital, London, United Kingdom
McMaster University, Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada
Janssen Research & Development, LLC, United States
Thrombosis and Hematology Therapeutic Area, Clinical Development, Pharmaceuticals, Bayer U.S. LLC, Whippany, United States
College of Public Health, The University of Oklahoma Health Sciences Center, Oklahoma City, United States
United States
Italy
France
United Kingdom
Canada
N/A
N/A
N/A
Creatinine
rivaroxaban
N/A
Randomized
Placebo Control
Double Blind/Blinded
NA
N/A
N/A
N/A